SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 2011-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
13
Active:0
Completed:3
Trial Phases
3 Phases
Phase 2:1
Phase 4:3
Not Applicable:8
Drug Approvals
4
TGA:4
Drug Approvals
Amnion - South Eastern Sydney Local Health District (303207)
- Product Name
- Amniotic membrane, cryopreserved - L
- Approval Date
- May 18, 2018
TGA
Skin - South Eastern Sydney Local Health District (303206)
- Product Name
- Skin, split, cryopreserved - L
- Approval Date
- May 18, 2018
TGA
Ocular Tissue - South Eastern Sydney Local Health District (232298)
- Product Name
- Cornea, Organ culture - L
- Approval Date
- Dec 23, 2014
TGA
Musculoskeletal Tissue - South Eastern Sydney Local Health District (230233)
- Product Name
- Bone, Frozen, Irradiated-L
- Approval Date
- Nov 6, 2014
TGA
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Not Applicable
8 (66.7%)Phase 4
3 (25.0%)Phase 2
1 (8.3%)The International ITP Registry
- Conditions
- Thrombocytopenia
- First Posted Date
- 2013-10-28
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- South Eastern Sydney Local Health District
- Target Recruit Count
- 500
- Registration Number
- NCT01970189
- Locations
- 🇦🇺
Canberra Hospital, Canberra, Australian Capital Territory, Australia
🇦🇺St George Hospital, Sydney, New South Wales, Australia
🇦🇺Calvary Mater Newcastle, Sydney, New South Wales, Australia
News
No news found